San Diego, CA -- (SBWire) -- 09/29/2022 --A deadline is coming up on October 4, 2022 in the lawsuit filed for certain investors of Kiromic BioPharma, Inc. (NASDAQ: KRBP).
Investors who purchased shares of Kiromic BioPharma, Inc. (NASDAQ: KRBP) have certain options and there are strict and short deadlines running. Deadline: October 4, 2022. NASDAQ: KRBP stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Kiromic BioPharma, Inc. (NASDAQ: KRBP) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents failed to disclose that the FDA had, prior to the filing of the Registration Statement and Prospectus, imposed a clinical hold, and in fact, contained statements indicating that it had not. Given that the Offering closed on July 2, 2021, more than thirty (30) days after the Company submitted the IND applications for its two immunotherapy product candidates, investors were assured that no clinical hold had been issued and clinical trials would commence.
Those who purchased shares of Kiromic BioPharma, Inc. (NASDAQ: KRBP) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Kiromic BioPharma, Inc. (NASDAQ:KRBP) Investor Notice: Deadline in Lawsuit on October 4, 2022
A Deadline is coming up on October 4, 2022 in the lawsuit for certain investors in Kiromic BioPharma, Inc. (NASDAQ:KRBP).